Oh....is ariad launching two new compounds this year, with an additional indication to immediately follow like ayzi!?
My bet is ARIAD gone by the end of summer. Gone meaning bought for $20/share. The rumors continue to swirl.
$20 a share is too good for them it seems. They're still around, but as of the date of this post, the stock price is under $10. Further, they seem desperate to hire PhD-level people within a Clin Dev and Safety, but it doesn't seem like they're having much luck, and give these postings, who can blame candidates from staying away?